Estrogen is able to inhibit proliferation, migration, and invasion and induce apoptosis of RCC cells through ERβ (estrogen receptor β) activation [29], suggesting a protective effect on survival, while androgen is able to promote RCC progression through androgen receptor [30]. Here, AR is linked to renal cell carcinoma.